This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Study of Haemodialysis Patients Switching From Ara...
Clinical trial

Study of Haemodialysis Patients Switching From Aranesp to Biosimilar (SHADE)

Read time: 1 mins
Last updated:7th Jul 2014

The study will obtain data to show insight into clinical outcomes of patients switching from Darbepoetin Alfa to a epoetin alfa biosimilar.

Category Value
Study start date 2014-07-07

View full details